Literature DB >> 17350202

Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.

Song-Hua Lee1, Chan-Eng Chong, Boon-San Lim, San-Jiun Chai, Kin-Kit Sam, Rahmah Mohamed, Sheila Nathan.   

Abstract

Burkholderia pseudomallei is a Gram-negative saprophytic soil bacterium, which is the etiologic agent of melioidosis, a severe and fatal infectious disease occurring in human and animals. Distinct clinical and animal isolates have been shown to exhibit differences in phenotypic trait such as growth rate, colony morphology, antimicrobial resistance, and virulence. This study was carried out to gain insight into the intrinsic differences between 4 clinical and 6 animal B. pseudomallei isolates from Malaysia. The 16S rRNA-encoding genes from these 10 isolates of B. pseudomallei were sequenced to confirm the identity of these isolates along with the avirulent Burkholderia thailandensis. The nucleotide sequences indicated that the 16S rRNA-encoding genes among the 10 B. pseudomallei isolates were identical to each other. However, the nucleotide sequence differences in the 16S rRNA-encoding genes appeared to be B. pseudomallei and B. thailandensis specific. The growth rate of all B. pseudomallei isolates was determined by generating growth curves at 37 degrees C for 72 h. The isolates were found to differ in growth rates with doubling time varying from 1.5 to 2.3 h. In addition, the B. pseudomallei isolates exhibited considerable variation in colony morphology when grown on Ashdown media, brain-heart infusion agar, and Luria-Bertani agar over 9 days of observation. Antimicrobial susceptibility tests indicated that 80% of the isolates examined were Amp(R) Cb(R) Kn(R) Gm(R) Chl(S) Te(S). Virulence of the B. pseudomallei clinical and animal isolates was evaluated in B. pseudomallei-susceptible BALB/c mice. Most of the clinical isolates were highly virulent. However, virulence did not correlate with isolate origin since 2 of the animal isolates were also highly virulent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350202     DOI: 10.1016/j.diagmicrobio.2007.01.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  24 in total

1.  Cloning, purification, crystallization and preliminary X-ray analysis of the Burkholderia pseudomallei L1 ribosomal protein.

Authors:  Abd Ghani Abd Aziz; Sergey N Ruzheinikov; Svetlana E Sedelnikova; Rahmah Mohamed; Sheila Nathan; Patrick J Baker; David W Rice
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-22

2.  Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment.

Authors:  Yao-Shen Chen; Wun-Ju Shieh; Cynthia S Goldsmith; Maureen G Metcalfe; Patricia W Greer; Sherif R Zaki; Hsin-Hou Chang; Hao Chan; Ya-Lei Chen
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

3.  Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei.

Authors:  Chui-Yoke Chin; Denise M Monack; Sheila Nathan
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

4.  AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.

Authors:  Krishnamurthy Narasimha Rao; Anirudha Lakshminarasimhan; Sarah Joseph; Swathi U Lekshmi; Ming-Seong Lau; Mohammed Takhi; Kandepu Sreenivas; Sheila Nathan; Rohana Yusof; Noorsaadah Abd Rahman; Murali Ramachandra; Thomas Antony; Hosahalli Subramanya
Journal:  Protein Sci       Date:  2015-04-02       Impact factor: 6.725

5.  Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization.

Authors:  Soon-Keat Ooi; Tian-Yeh Lim; Song-Hua Lee; Sheila Nathan
Journal:  Virulence       Date:  2012-10-01       Impact factor: 5.882

6.  Crystallization and preliminary X-ray analysis of the receiver domain of a putative response regulator, BPSL0128, from Burkholderia pseudomallei.

Authors:  Abd Ghani Abd Aziz; Svetlana E Sedelnikova; Sergey N Ruzheinikov; Simon Thorpe; Rahmah Mohamed; Sheila Nathan; John B Rafferty; Patrick J Baker; David W Rice
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

7.  Cloning, purification and crystallographic analysis of a hypothetical protein, BPSL1549, from Burkholderia pseudomallei.

Authors:  Abimael Cruz-Migoni; Sergey N Ruzheinikov; Svetlana E Sedelnikova; Barbara Obeng; Sylvia Chieng; Rahmah Mohamed; Sheila Nathan; Patrick J Baker; David W Rice
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-30

8.  Burkholderia pseudomallei transcriptional adaptation in macrophages.

Authors:  Sylvia Chieng; Laura Carreto; Sheila Nathan
Journal:  BMC Genomics       Date:  2012-07-23       Impact factor: 3.969

9.  Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.

Authors:  Chui-Yoke Chin; Swee-Chen Tan; Sheila Nathan
Journal:  Front Cell Infect Microbiol       Date:  2012-06-15       Impact factor: 5.293

10.  Computational discovery and RT-PCR validation of novel Burkholderia conserved and Burkholderia pseudomallei unique sRNAs.

Authors:  Jia-Shiun Khoo; Shiao-Fei Chai; Rahmah Mohamed; Sheila Nathan; Mohd Firdaus-Raih
Journal:  BMC Genomics       Date:  2012-12-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.